MLLT3 and melanoma: To support our hypothesis, scRNA showed significant changes in the cell subpopulations of melanoma cells with MLLT3 knockout, activating the TP53 and MAPK pathways, providing evidence for the involvement of MLLT3 in melanoma cell proliferation, metastasis, and stem cell changes at the single‐cell level.